ng-nitroarginine methyl ester and Heart Diseases

ng-nitroarginine methyl ester has been researched along with Heart Diseases in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	3 (37.50)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agüero, J; Almenar, L; Buendía, F; DʼOcon, P; Ivorra, MD; Montó, F; Muedra, V; Noguera, MA; Oliver, E; Rovira, E; Rueda, J; Valldecabres, C; Vicente, D	1
Dehpour, AR; Doostar, Y; Ebrahimi, F; Ghasemi, M; Hashemi, M; Moezi, L; Shafaroodi, H	1
Biwer, LA; Broderick, TL; Carroll, C; Hale, TM; Xu, H	1
Frohlich, ED; Zhou, X	1
Ba, ZF; Bland, KI; Chaudry, IH; Chen, J; Choudhry, MA; Hsu, JT; Kan, WH; Schwacha, MG	1
Heavner, JE; Pitkänen, M; Shi, B	1
Musch, TI; Stebbins, CL; Symons, JD	1
Adler, GK; Martinez, DV; Matsumura, M; Ochoa-Maya, M; Oestreicher, E; Rocha, R; Roubsanthisuk, W; Williams, GH	1

Reviews

1 review(s) available for ng-nitroarginine methyl ester and Heart Diseases

Article	Year
Analogy of cardiac and renal complications in essential hypertension and aged SHR or L-NAME/SHR. Medicinal chemistry (Shariqah (United Arab Emirates)), 2007, Volume: 3, Issue:1 Topics: Aging; Animals; Antihypertensive Agents; Disease Models, Animal; Enzyme Inhibitors; Heart Diseases; Hypertension; Kidney Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR	2007

Article

Year

Analogy of cardiac and renal complications in essential hypertension and aged SHR or L-NAME/SHR.

Medicinal chemistry (Shariqah (United Arab Emirates)), 2007, Volume: 3, Issue:1

Topics: Aging; Animals; Antihypertensive Agents; Disease Models, Animal; Enzyme Inhibitors; Heart Diseases; Hypertension; Kidney Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR

2007

Other Studies

7 other study(ies) available for ng-nitroarginine methyl ester and Heart Diseases

Article	Year
β2- and β1-Adrenoceptor Expression Exhibits a Common Regulatory Pattern With GRK2 and GRK5 in Human and Animal Models of Cardiovascular Diseases. Journal of cardiovascular pharmacology, 2015, Volume: 66, Issue:5 Topics: Animals; Case-Control Studies; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 5; Gene Expression Regulation; Heart Diseases; Humans; Hypertension; NG-Nitroarginine Methyl Ester; Organ Specificity; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; RNA, Messenger	2015
Cholestasis induces apoptosis in mice cardiac cells: the possible role of nitric oxide and oxidative stress. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:6 Topics: Animals; Apoptosis; Bile Ducts; Catalase; Cholestasis; Disease Models, Animal; Enzyme Inhibitors; Glutathione Peroxidase; Heart Diseases; Ligation; Lipid Peroxidation; Male; Malondialdehyde; Mice; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Superoxide Dismutase	2010
Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment. Acta physiologica (Oxford, England), 2013, Volume: 207, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Pressure; Cardiac Output; Coronary Circulation; Drug Interactions; Enalapril; Enzyme Inhibitors; Heart Diseases; Heart Function Tests; Heart Rate; Hypertension; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Time Factors; Ventricular Remodeling	2013
p38 MAPK-dependent eNOS upregulation is critical for 17beta-estradiol-mediated cardioprotection following trauma-hemorrhage. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:6 Topics: Abdomen; Animals; Calmodulin; Cardiotonic Agents; Caveolin 1; Chemokine CXCL1; Chemokine CXCL2; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Estradiol; Heart Diseases; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Mitogen-Activated Protein Kinase 11; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Peroxidase; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation; Ventricular Function	2008
Nitric oxide synthesis inhibition modifies the cardiotoxicity of tetracaine and lidocaine. Anesthesia and analgesia, 1999, Volume: 88, Issue:4 Topics: Anesthetics, Local; Animals; Biotransformation; Blood Gas Analysis; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Heart Diseases; Hemodynamics; Lidocaine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Tetracaine	1999
Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats. Journal of applied physiology (Bethesda, Md. : 1985), 1999, Volume: 87, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Female; Heart Diseases; Heart Rate; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow	1999
Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:2 Pt 2 Topics: Aldosterone; Angiotensin II; Animals; Diet, Sodium-Restricted; Disease Models, Animal; Eplerenone; Heart Diseases; Male; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Potassium; Rats; Rats, Wistar; Spironolactone	2002